PReS-FINAL-2161: Safety and effectiveness of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to <4 years or >=4 years weighing <15 kg

by Kingsbury, D, Quartier, P, Arora, V, Kalabic, J, Kupper, H, Mozaffarian, N
Published 2013

PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis

by Ruperto, N, Lovell, DJ, Jarosova, K, Nemcova, D, Vargová, V, Michels, H, Chalom, EC, Ilowite, N, Wouters, C, Brunner, HI, Kracht, KK, Kupper, H, Giannini, E, Martini, A, Mozaffarian, N
Published 2013